PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10362188-1	1999	OBJECTIVES: This study examined the effect of a small-molecule, direct thrombin inhibitor, argatroban, on reperfusion induced by tissue plasminogen activator (TPA) in patients with acute myocardial infarction (AMI).	argatroban	91-101	chromosome 20 open reading frame 181	Homo sapiens	129-157	
10362188-1	1999	OBJECTIVES: This study examined the effect of a small-molecule, direct thrombin inhibitor, argatroban, on reperfusion induced by tissue plasminogen activator (TPA) in patients with acute myocardial infarction (AMI).	argatroban	91-101	chromosome 20 open reading frame 181	Homo sapiens	159-162	
10362188-3	1999	In vitro and in vivo studies have shown that argatroban has advantages over heparin for the inhibition of clot-bound thrombin and for the enhancement of thrombolysis with TPA.	argatroban	45-55	chromosome 20 open reading frame 181	Homo sapiens	171-174	
28754831-0	2017	Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".	argatroban	77-87	chromosome 20 open reading frame 181	Homo sapiens	105-133	
10751791-0	1998	Comparison of Argatroban and Hirudin for the Reperfusion of Thrombotic Arterial Occlusion by Tissue Plasminogen Activator.	argatroban	14-24	chromosome 20 open reading frame 181	Homo sapiens	93-121